Literature DB >> 33662110

Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma.

Aly-Khan A Lalani1, Ziad Bakouny2, Subrina Farah3, Frede Donskov4, Shaan Dudani5, Daniel Y C Heng6, Toni K Choueiri2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33662110      PMCID: PMC7934079          DOI: 10.1001/jamaoncol.2021.0019

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

Review 1.  Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets.

Authors:  Sze Kiat Tan; Helen Y Hougen; Jaime R Merchan; Mark L Gonzalgo; Scott M Welford
Journal:  Nat Rev Urol       Date:  2022-10-03       Impact factor: 16.430

2.  The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective.

Authors:  Katharina Knoll; Elisabeth Reiser; Katharina Leitner; Johanna Kögl; Christoph Ebner; Christian Marth; Irina Tsibulak
Journal:  Arch Gynecol Obstet       Date:  2021-09-24       Impact factor: 2.344

3.  Impact of Body Mass Index on Survival Outcomes of Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis.

Authors:  Kosuke Takemura; Satoru Yonekura; Laura E Downey; Dimitris Evangelopoulos; Daniel Y C Heng
Journal:  Eur Urol Open Sci       Date:  2022-04-04

4.  Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.

Authors:  Dylan J Martini; T Anders Olsen; Subir Goyal; Yuan Liu; Sean T Evans; Benjamin Magod; Jacqueline T Brown; Lauren Yantorni; Greta Anne Russler; Sarah Caulfield; Jamie M Goldman; Bassel Nazha; Haydn T Kissick; Wayne B Harris; Omer Kucuk; Bradley C Carthon; Viraj A Master; Mehmet Asim Bilen
Journal:  Front Oncol       Date:  2021-07-09       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.